ABSTRACT - 597657 The disclosure relates to a use of a composition comprising as an active ingredient sulphur particles less than 300 microns and sodium lignin sulfonate, in the manufacture of a medicament for treating lung and respiratory disorders, bone, joint and muscle disorders, digestive disorders, diabetes, cancer and/or viral infections, in a patient in need thereof.